Literature DB >> 3874461

The effect of hormone therapy on peripheral blood leukocytic subset distribution in stage D prostatic cancer patients.

M Rubenstein, M W Shaw, C F McKiel, M Stobnicki, R J Ablin, P D Guinan.   

Abstract

The distribution of mononuclear cell types found in the peripheral blood of patients bearing carcinoma of the prostate were compared by stage and to a control group using monoclonal antibody techniques. Patients with lower stage disease (A, B) had no significant alteration in subset distribution when compared to a control group, while those with higher stage disease (D) had significant deviations. Stage D patients had a decreased representation of helper-inducer T cells and an increased representation of suppressor-cytotoxic T cells, with an overall reduction in the total T cell content. In addition elevated levels of monocytic, granulocytic and null cells were recognized by the polyspecific OKM1 antibody. These differences were in part reversible following hormonal therapy. Such alterations in the ratios between the various T cell populations could be useful in patient staging and treatment selection.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3874461     DOI: 10.1007/bf00261568

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  17 in total

Review 1.  Occult carcinoma of the prostate: an oversight of immune surveillance--a working hypothesis.

Authors:  R F Gittes; D L McCullough
Journal:  J Urol       Date:  1974-08       Impact factor: 7.450

Review 2.  Proceedings: The natural history of prostatic cancer.

Authors:  W F Whitmore
Journal:  Cancer       Date:  1973-11       Impact factor: 6.860

Review 3.  Binding of bacteria to lymphocyte subpopulations.

Authors:  M Teodorescu; E P Mayer
Journal:  Adv Immunol       Date:  1982       Impact factor: 3.543

4.  Strategies for generating monoclonal antibodies defining human t-lymphocyte differentiation antigens.

Authors:  P C Kung; M A Talle; M E DeMaria; M S Butler; J Lifter; G Goldstein
Journal:  Transplant Proc       Date:  1980-09       Impact factor: 1.066

5.  Monoclonal antibodies to human T lymphocyte surface antigens: their potential application to urology.

Authors:  A W Ritchie; K James; G D Chisholm
Journal:  Urol Res       Date:  1982

6.  T-lymphocyte subsets in follicular lymphomas compared with those in non-neoplastic lymph nodes and tonsils.

Authors:  P Dvoretsky; G S Wood; R Levy; R A Warnke
Journal:  Hum Pathol       Date:  1982-07       Impact factor: 3.466

7.  Sex steroid receptors in peripheral T cells: absence of androgen receptors and restriction of estrogen receptors to OKT8-positive cells.

Authors:  J H Cohen; L Danel; G Cordier; S Saez; J P Revillard
Journal:  J Immunol       Date:  1983-12       Impact factor: 5.422

8.  The prognostic value of T-lymphocyte levels in malignant melanoma. A five-year follow-up.

Authors:  M G Bernengo; F Lisa; M Meregalli; A De Matteis; G Zina
Journal:  Cancer       Date:  1983-11-15       Impact factor: 6.860

9.  Influence of in vivo diethylstilbosterol phosphate on some human blood lymphocyte sub-populations.

Authors:  M Onsrud; S Sander
Journal:  Acta Pathol Microbiol Immunol Scand C       Date:  1982-10

10.  Effect of treatment with diethylstilbestrol-polyestradiol phosphate or estramustine phosphate (estracyt) on natural killer cell activity in patients with prostatic cancer.

Authors:  T Kalland; S Haukaas
Journal:  Invest Urol       Date:  1981-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.